These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 33841435)

  • 1. Neutrophils in COVID-19.
    Reusch N; De Domenico E; Bonaguro L; Schulte-Schrepping J; Baßler K; Schultze JL; Aschenbrenner AC
    Front Immunol; 2021; 12():652470. PubMed ID: 33841435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 and Neutrophils: The Relationship between Hyperinflammation and Neutrophil Extracellular Traps.
    Borges L; Pithon-Curi TC; Curi R; Hatanaka E
    Mediators Inflamm; 2020; 2020():8829674. PubMed ID: 33343232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-Cell Transcriptome Analysis Highlights a Role for Neutrophils and Inflammatory Macrophages in the Pathogenesis of Severe COVID-19.
    Shaath H; Vishnubalaji R; Elkord E; Alajez NM
    Cells; 2020 Oct; 9(11):. PubMed ID: 33138195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-analysis of Single Cell Transcriptome Reveals That the NR3C1-CXCL8-Neutrophil Axis Determines the Severity of COVID-19.
    Park JH; Lee HK
    Front Immunol; 2020; 11():2145. PubMed ID: 32983174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel.
    Napodano C; Pocino K; Stefanile A; Marino M; Miele L; Gulli F; Basile V; Pandolfi F; Gasbarrini A; Rapaccini GL; Basile U
    Scand J Immunol; 2021 Mar; 93(3):e12977. PubMed ID: 32931622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced Expression of Autoantigens During SARS-CoV-2 Viral Infection.
    Saheb Sharif-Askari N; Saheb Sharif-Askari F; Ahmed SBM; Hannawi S; Hamoudi R; Hamid Q; Halwani R
    Front Immunol; 2021; 12():686462. PubMed ID: 34276672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophils mediate Th17 promotion in COVID-19 patients.
    Parackova Z; Bloomfield M; Klocperk A; Sediva A
    J Leukoc Biol; 2021 Jan; 109(1):73-76. PubMed ID: 33289169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies in severe COVID-19-related acute respiratory distress syndrome: Just innocent bystanders?
    Umbrello M; Nespoli S; Pisano E; Bonino C; Muttini S
    Int J Rheum Dis; 2021 Mar; 24(3):462-464. PubMed ID: 33539677
    [No Abstract]   [Full Text] [Related]  

  • 9. Repurposing CD8
    Gujar S; Pol JG; Kim Y; Kroemer G
    Oncoimmunology; 2020 Jul; 9(1):1794424. PubMed ID: 32923158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.
    Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T
    Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2-induced immunodysregulation and the need for higher clinical suspicion for co-infection and secondary infection in COVID-19 patients.
    Parrill A; Tsao T; Dong V; Huy NT
    J Microbiol Immunol Infect; 2021 Feb; 54(1):105-108. PubMed ID: 32943328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19.
    Tomar B; Anders HJ; Desai J; Mulay SR
    Cells; 2020 Jun; 9(6):. PubMed ID: 32498376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 Hyperinflammation: What about Neutrophils?
    Didangelos A
    mSphere; 2020 Jun; 5(3):. PubMed ID: 32581077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19: Significance of antibodies.
    Assadiasl S; Fatahi Y; Zavvar M; Nicknam MH
    Hum Antibodies; 2020; 28(4):287-297. PubMed ID: 32986664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets.
    Hazeldine J; Lord JM
    Front Immunol; 2021; 12():680134. PubMed ID: 34149717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of COVID-19 pandemic on EJI and the extended immunological community.
    Di Santo J
    Eur J Immunol; 2021 Jan; 51(1):8-9. PubMed ID: 33616920
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunity to glycan α-Gal and possibilities for the control of COVID-19.
    la Fuente J; Gortázar C; Cabezas-Cruz A
    Immunotherapy; 2021 Feb; 13(3):185-188. PubMed ID: 33307805
    [No Abstract]   [Full Text] [Related]  

  • 18. The known unknowns of T cell immunity to COVID-19.
    Karlsson AC; Humbert M; Buggert M
    Sci Immunol; 2020 Nov; 5(53):. PubMed ID: 33208380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological imprint of COVID-19 on human peripheral blood leukocyte populations.
    Kratzer B; Trapin D; Ettel P; Körmöczi U; Rottal A; Tuppy F; Feichter M; Gattinger P; Borochova K; Dorofeeva Y; Tulaeva I; Weber M; Grabmeier-Pfistershammer K; Tauber PA; Gerdov M; Mühl B; Perkmann T; Fae I; Wenda S; Führer H; Henning R; Valenta R; Pickl WF
    Allergy; 2021 Mar; 76(3):751-765. PubMed ID: 33128792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical and Clinical Analysis of Two Automated Anti-SARS-CoV-2 Immunoassays in Pre-Pandemic and Pandemic Patient Populations.
    Yang J; Pederson EC; Hamilton C; Neibauer T; Robyak K; McGhee P; Speicher T; Zhu Y
    J Appl Lab Med; 2021 Mar; 6(2):441-450. PubMed ID: 33152084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.